[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100626273":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":38,"centralContacts":42,"locations":52,"responsibleParty":94,"collaborators":96,"id":105,"slug":106,"hasResults":107,"nctId":108,"briefTitle":109,"officialTitle":110,"acronym":111,"eligibilityCriteria":112,"healthyVolunteers":107,"sex":113,"minAge":114,"maxAge":115,"enrollmentInfo":116,"targetDuration":46,"studyType":119,"phases":120,"briefSummary":122,"conditions":123,"keywords":129,"overallStatus":150,"whyStopped":46,"lastUpdateSubmitDate":151,"lastUpdatePostDateStruct":152,"startDateStruct":155,"completionDateStruct":157,"leadSponsor":159,"locationsCount":160},{"fullName":5,"class":6},"Helse Fonna","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Blue-blocking glasses","EXPERIMENTAL","Blue-blocking glasses (BB-glasses) or real darkness from 9 p.m. to desired wake-up time + application of dark mode setting on the participant's mobile phone (if not already in use) + registration of brightness on participant's mobile phone screen (%) + treatment as usual",[13],"Device: Blue-blocking glasses (BB-glasses) or real darkness from 9 p.m. to desired wake-up time + night mode setting on mobile phone",{"label":15,"type":16,"description":17,"interventionNames":18},"Dark mode (mobile phone)","ACTIVE_COMPARATOR","Application of dark mode setting on the participant's mobile phone (if not already in use) + registration of brightness on participants' mobile phone screen (%) + treatment as usual",[19],"Other: Control",[21,31],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","Blue-blocking glasses (BB-glasses) or real darkness from 9 p.m. to desired wake-up time + night mode setting on mobile phone","Blue-blocking glasses and night mode on mobile phoneBlue-blocking glasses (BB-glasses) or real darkness from 9 p.m. to desired wake-up time + application of dark mode setting on the participant's mobile phone (if not already in use) + registration of brightness on participant's mobile phone screen (%) + treatment as usual",[9],[27,28,29,30],"Virtual darkness","Orange glasses","Amber lenses","Blue-blocking light filters",{"type":6,"name":32,"description":33,"armGroupLabels":34,"otherNames":35},"Control","Application of dark mode setting on the participant's mobile phone (if not already in use) + registration of brightness on particpants's mobile phone screen (%) + Treatment as usual",[15],[36,37],"Dark mode","Night mode",[39],{"name":40,"affiliation":5,"role":41},"Tone Elise G Henriksen, MD PhD","PRINCIPAL_INVESTIGATOR",[43,48],{"name":40,"role":44,"phone":45,"phoneExt":46,"email":47},"CONTACT","004753473240",null,"tgjo@helse-fonna.no",{"name":49,"role":44,"phone":50,"phoneExt":46,"email":51},"Marit Nymoen, PhD","0052732805","marit.nymoen@helse-fonna.no",[53,74],{"facility":54,"status":46,"city":55,"state":56,"zip":57,"country":58,"countryCode":59,"cosmosGeoPoint":60,"geoPoint":65,"contacts":66},"BUP Haugesund","Haugesund","Rogaland","5520","Norway","NO",{"type":61,"coordinates":62},"Point",[63,64],5.268,59.41378,{"lat":64,"lon":63},[67,71],{"name":68,"role":44,"phone":69,"phoneExt":46,"email":70},"Sigrund Drivenes, MSc","004752732805","sigrund.drivenes@helse-fonna.no",{"name":72,"role":44,"phone":69,"phoneExt":46,"email":73},"Georg W Reinhardt, MD","georg.walter.reinhardt@helse-fonna.no",{"facility":75,"status":46,"city":76,"state":77,"zip":78,"country":58,"countryCode":59,"cosmosGeoPoint":79,"geoPoint":83,"contacts":84},"BUPA Tromsø, The University Hospital of North Norway","Tromsø","Troms","9019",{"type":61,"coordinates":80},[81,82],18.95508,69.6489,{"lat":82,"lon":81},[85,90],{"name":86,"role":44,"phone":87,"phoneExt":88,"email":89},"Christian Eckhoff, MD, PhD","+47761700700","+47","christian.eckhoff@uit.no",{"name":91,"role":44,"phone":92,"phoneExt":88,"email":93},"Judeson Joseph, MD","+4776170700","judeson.joseph@unn.no",{"type":95,"investigatorFullName":46,"investigatorTitle":46,"investigatorAffiliation":46,"oldNameTitle":46,"oldOrganization":46},"SPONSOR",[97,99,101,103],{"name":98,"class":6},"University of Bergen",{"name":100,"class":6},"University of Oslo",{"name":102,"class":6},"University Hospital of North Norway",{"name":104,"class":6},"Helse Vest","100626273","blue-blocking-glasses-for-sleep-disorders-in-child-and-adolescent-psychiatry-100626273",false,"NCT07433491","Blue-blocking Glasses for Sleep Disorders in Child and Adolescent Psychiatry","Blue-blocking Glasses for Treating Evening Activation and Sleep Disorders in Child and Adolescent Psychiatry - a Pilot Trans-diagnostic Randomized Controlled Trial.","BATCAT-pilot","Inclusion Criteria:\n\n* Age 12-18 years, receiving health-care from child and adolescent mental health services at UPA University Hospital of North Norway, Tromsø or BUP Haugesund Hospital, Haugesund\n* Current Insomnia or DSPD comorbid to one or several pychiatric symptom presentations or diagnoses\n* Able and willing to provide written informed consent\n* Participants aged 12-15,9 years also need consent from both parents\u002Fcarers\n* Able to comply with protocol\n* Able to discontinue melatonin or BB-glasses if currently used, with at least 3 days washout period\n\nExclusion Criteria:\n\n* Not able to comply with protocol for a required minimum of one night\n* Blindness or severely reduced translucency of both eyes\n* Known malformation or damage of optical tract blindness\n* Use of melatonin all formulas that cannot be paused\n* High risk for suicide or self-harm\n* Consent from both partents\u002Fcarers unlikely (participants age 12-15,9 years)","ALL","12 Years","18 Years",{"count":117,"type":118},40,"ESTIMATED","INTERVENTIONAL",[121],"NA","Sleep problems and regulation difficulties are frequent in the child and adolescent psychiatry population. Insomnia and delayed sleep-wake phase disorders (DSPWD) are highly prevalent, and risk factors for developing more severe illness courses and chronic disorders. Pharmacological treatments of sleep disorders dominate even for the youngest patients but are unsupported by long-term data on outcome and side effects. The majority of non-pharmacological treatment options are composite and resource demanding. The investigators will examine the effects and feasibility of the isolated intervention of evening\u002Fnight use of blue-blocking glasses\u002Freal darkness as adjunctive treatment for insomnia and delayed sleep phase disorder in inpatient and outpatient settings for children and adolecents.",[124,125,126,127,128],"Insomnia","Delayed Sleep Phase Disorder","Hyperarousal","Transdiagnostic Psychopathology","Child and Adolescent Psychiatry",[130,131,132,133,134,135,136,137,138,9,139,140,141,142,143,144,145,146,147,148,149],"children","adolescents","child and adolescent psychiatry","insomnia","delayed sleep phase disorder","hyperarousal","sleep","hospital ward","outpatients","virtual dark therapy","blue-blocking interventention","mobile-phone","screen","actigraphy","6-sulfatoxymelatonin","Heart Rate Variability","light","activation","melatonin","inpatients","NOT_YET_RECRUITING","2026-02-24",{"date":153,"type":154},"2026-02-25","ACTUAL",{"date":156,"type":118},"2026-02-01",{"date":158,"type":118},"2027-06-01",{"name":5,"class":6},2]